Jui‐Feng Hsu

Additional chromosome abnormalities in chronic myeloid leukemia

Hui‐Hua Hsiao, Yi‐Chang Liu, Hui‐Jen Tsai et al. · The Kaohsiung Journal of Medical Sciences · 2011 · 19 citations · Full text

MDM2 promoter polymorphism and p53 codon 72 polymorphism in chronic myeloid leukemia: The association between MDM2 promoter genotype and disease susceptibility, age of onset, and blast‐free survival in chronic phase patients receiving imatinib

Yi‐Chang Liu, Hui‐Hua Hsiao, Wen‐Chi Yang et al. · Molecular Carcinogenesis · 2013 · 15 citations

Regression of a metastatic lung mass after receiving whole brain irradiation: Can the abscopal effect cross the blood–brain barrier?

Cheng‐Hao Chuang, Jui‐Feng Hsu, Yuting Shen et al. · Asia-Pacific Journal of Clinical Oncology · 2018 · 15 citations

Clinical efficacy of concurrent bevacizumab for malignant ascites in nonsquamous cell carcinoma of the lung

Jui‐Feng Hsu, Yen‐Lung Lee, Hsu‐Liang Chang et al. · Asia-Pacific Journal of Clinical Oncology · 2019 · 11 citations

Dasatinib‐induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review

Chao‐Chin Hsu, Jui‐Feng Hsu, Kuan‐Li Wu · Respirology Case Reports · 2021 · 11 citations · Full text